Cancer Chemotherapy and Pharmacology

, Volume 68, Issue 2, pp 359–369 | Cite as

Conjugation of chlorin p6 to histamine enhances its cellular uptake and phototoxicity in oral cancer cells

Original Article

Abstract

Purpose

Our previous studies in hamster cheek pouch model have shown that chlorin p6 (Cp6), a chlorophyll derivative is a suitable photosensitizer for photodynamic treatment (PDT) of small tumors (<5 mm). However, for bigger tumors, the accumulation of Cp6 was inadequate, which compromised the effectiveness of PDT. The purpose of present study was to investigate the possibility of improving the cellular uptake of Cp6 by conjugating it to histamine, a biogenic amine that is known to modulate tumor growth and development via cell surface receptors.

Methods

The conjugate of Cp6 and histamine (Cp6-his) was prepared by carbodiimide coupling reaction. Cellular uptake, intracellular localization and cytotoxicity of both Cp6 and its conjugate were investigated in two human oral cancer cell lines (4451 and NT8e). The percentage of necrotic and apoptotic cells after PDT were also estimated using Hoechst 33342–propidium iodide staining.

Results

In both the cell line, the cellular uptake of Cp6-his was found to be ~10 times higher when compared to Cp6. Histamine led to a slight increase in intracellular uptake of Cp6-his, whereas ranitidine, a histamine H2 receptor antagonist, and incubation at lower temperature (~15°C) led to its inhibition, suggesting that uptake of Cp6-his is receptor mediated. Results on western blot confirmed the presence of H2 receptor in both the cell line. Observations on intracellular localization revealed that unlike Cp6, which localized on multiple sites, Cp6-his showed localization on the cell membrane and around the perinuclear region. Moreover, the phototoxicity induced by Cp6-his was ~4 times higher when compared to Cp6 in both the cell lines. There was, however, no significant difference in the mode of cell death.

Conclusion

Results suggest that conjugating Cp6 with histamine can help improve the effectiveness of PDT in oral cancer cells by enhancing its intracellular delivery.

Keywords

Chlorophyll derivative Photodynamic therapy Mode of cell death Targeted delivery 

Notes

Acknowledgments

Authors would like to thank Dr. A. Datta, IIT Mumbai for mass spectroscopy measurements, Dr. BS Dwarakanath, INMAS, Delhi and Dr. R Mulherkar, ACTREC, Mumbai for providing oral cancer cell line.

References

  1. 1.
    Brown SB, Brown EA, Walker I (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5:497–508PubMedCrossRefGoogle Scholar
  2. 2.
    Wilson BC, Patterson MS (2008) The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 53:R61–R109PubMedCrossRefGoogle Scholar
  3. 3.
    Nyman ES, Hynninen PH (2004) Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B Biol 73:1–28CrossRefGoogle Scholar
  4. 4.
    Dube A, Sharma S, Gupta PK (2006) Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Oral Oncol 42:77–82PubMedCrossRefGoogle Scholar
  5. 5.
    Sharman WM, van Lier JE, Allen CM (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Delv Rev 56:53–76CrossRefGoogle Scholar
  6. 6.
    Chen B, Pogue BW, Hoopes PJ, Hasan T (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16:279–305PubMedGoogle Scholar
  7. 7.
    Schneider E, Rolli-Derkinderen M, Arock M, Dy M (2002) Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23:255–263PubMedCrossRefGoogle Scholar
  8. 8.
    Bartholeyns J, Fozard JR (1985) Role of histamine in tumor development. Trends Pharmacol Sci 6:123–125CrossRefGoogle Scholar
  9. 9.
    Medina MA, Quesada AR, de Núñez Castro I, Sánchez-Jiménez F (1999) Histamine, polyamines, and cancer. Biochem Pharmacol 57:1341–1344PubMedCrossRefGoogle Scholar
  10. 10.
    Rivera ES, Cricco GP, Engel NI, Fitzsimons CP, Martín GA, Bergoc RM (2000) Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin Cancer Biol 10:15–23PubMedCrossRefGoogle Scholar
  11. 11.
    Pós Z, Sáfrány G, Müller K, Tóth S, Falus A, Hegyesi H (2005) Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers. Cancer Res 65:4458–4466PubMedCrossRefGoogle Scholar
  12. 12.
    Medina VA, Rivera ES (2010) Histamine receptors and cancer pharmacology. Br J Pharmacol 161:755–767PubMedCrossRefGoogle Scholar
  13. 13.
    Szabó PM, Wiener Z, Tömböl Z, Kovács A, Pócza P, Horányi J, Kulka J, Riesz P, Tóth M, Patócs A, Gaillard RC, Falus A, Rácz K, Igaz P (2009) Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchows Arch 455:133–142PubMedCrossRefGoogle Scholar
  14. 14.
    Hoober JK, Sery TW, Yamamoto N (1988) Photodynamic sensitizers from chlorophyll: purpurin-18 and chlorin p6. Photochem Photobiol 48:579–582PubMedCrossRefGoogle Scholar
  15. 15.
    Mosman T (1983) Rapid colorimetric assay for cellular growth and survival application and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefGoogle Scholar
  16. 16.
    Fukushima Y, Asano T, Saitoh T, Anai M, Funaki M, Ogihara T, Katagiri H, Matsuhashi N, Yazaki Y, Sugano K (1997) Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells. FEBS Lett 409:283–286PubMedCrossRefGoogle Scholar
  17. 17.
    Van der Goot H, Timmerman H (2000) Selective ligands as tools to study histamine receptors. Eur J Med Chem 35:5–20PubMedCrossRefGoogle Scholar
  18. 18.
    Ogasawara M, Yamauchi K, Satoh Y, Yamaji R, Inui K, Jonker J, Schinkel A, Maeyama K (2006) Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci 101:24–30PubMedCrossRefGoogle Scholar
  19. 19.
    Corbel S, Traiffort E, Stark H, Schunack W, Dy M (1997) Binding of histamine H3-receptor antagonists to hematopoietic progenitor cells—evidence for a histamine transporter unrelated to histamine H3 receptors. FEBS Lett 404:289–293PubMedCrossRefGoogle Scholar
  20. 20.
    Schneider E, Machavoine F, Pléau J, Bertron A, Thurmond R, Ohtsu H, Watanabe T, Schinkel A, Dy M (2005) Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels. JEM 202:387–393CrossRefGoogle Scholar
  21. 21.
    Mojzisova H, Bonneau S, Vever-Bizet C, Brault D (2007) Cellular uptake and subcellular distribution of chlorin e6 as functions of pH and interactions with membranes and lipoproteins. Biochim Biophys Acta 1768:2748–2756PubMedCrossRefGoogle Scholar
  22. 22.
    Fernandez N, Monczor F, Baldi A, Davio C, Shayo C (2008) Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization. Mol Pharmacol 74:1109–1118PubMedCrossRefGoogle Scholar
  23. 23.
    Osawa S, Kajimura M, Yamamoto S, Ikuma M, Mochizuki C, Iwasaki H, Hishida A, Terakawa S (2005) Alteration of intracellular histamine H2 receptor cycling precedes antagonist-induced upregulation. Am J Physiol Gastrointest Liver Physiol 289:G880–G889PubMedCrossRefGoogle Scholar
  24. 24.
    LaBella FS, Brandes LJ (2000) Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs. Semin Cancer Biol 10:47–53PubMedCrossRefGoogle Scholar
  25. 25.
    Morissette G, Lodge R, Bouthillier J, Marceau F (2008) Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects. Toxicol Appl Pharmacol 229:320–331PubMedCrossRefGoogle Scholar
  26. 26.
    Kessel D (1989) Determinants of photosensitization by mono–L-aspartyl chlorin e6. Photochem Photobiol 49:447–452PubMedCrossRefGoogle Scholar
  27. 27.
    Csaba G, Kovács P (2006) Perinuclear localization of biogenic amines (serotonin and histamine) in rat immune cells. Cell Biol Int 30:861–865PubMedCrossRefGoogle Scholar
  28. 28.
    Begum G, Dube A, Joshi PG, Gupta PK, Joshi NB (2009) Chlorin p6 preferentially localizes in endoplasmic reticulum and golgi apparatus and inhibits Ca2+ release from intracellular store. J Photochem Photobiol B Biol 95:177–184CrossRefGoogle Scholar
  29. 29.
    Koenig JA (2004) Signal reception: G protein-coupled receptors. In: Davies RW, Morris BJ (eds) Molecular biology of neurons, 2nd edn. Oxford, New York, pp 215–248 Google Scholar
  30. 30.
    Plaetzer K, Kiesslich T, Verwanger T, Krammer B (2003) The modes of cell death induced by PDT: an Overview. Med Laser Appl 18:7–19CrossRefGoogle Scholar
  31. 31.
    Gupta S, Dwarakanath BS, Muralidhar K, Jain V (2003) Cellular uptake, localization and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines. J Photochem Photobiol B Biol 69:107–120CrossRefGoogle Scholar
  32. 32.
    Mulherkar R, Goud AP, Wagle AS, Naresh KN, Mahimkar MB, Thomas SM, Pradhan SA, Deo MG (1997) Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract. Cancer Lett 118:115–121PubMedCrossRefGoogle Scholar
  33. 33.
    Burns TF, El-Deiry WS (1999) The p53 pathway and apoptosis. J Cell Physiol 181:231–239PubMedCrossRefGoogle Scholar
  34. 34.
    Sax JK, El-Deiry WS (2003) p53 downstream targets and chemosensitivity. Cell Death Differ 10:413–417PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Laser Biomedical Applications and Instrumentation DivisionRaja Ramanna Center for Advanced TechnologyIndoreIndia

Personalised recommendations